Nexentis Technologies Inc. SEC filings NXTS

Nexentis Technologies Inc. has 309 filings in SEC EDGAR's recent list, going back to Sep 26, 2019. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (unregistered share sale, officer or director change). The company's fiscal year ends on December 31.

Nexentis Technologies Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
10-Q Quarterly report May 18, 2021 Mar 31, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report Aug 11, 2020 Jun 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NXTS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1789192
Former names
N2OFF, Inc. (until Feb 25, 2026); Save Foods, Inc. (until Mar 19, 2024); Save Foods Inc. (until Apr 10, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.